항-갈렉틴-9 항체 및 이의 치료적 용도

티스렐리주맙과의 조합으로 항-갈렉틴-9 항체 (예를 들면, G9.2-17(IgG4))를 사용하여 고형 종양 (예를 들면, 두경부암, 요로상피 암종, 등)을 치료하는 방법. Methods for treating solid tumors (e.g., head and neck cancer, urothelial carcinoma, etc.) using an anti-Galectin-9 antibody (e.g., G9.2-17(IgG4)) in combination with tislelizumab....

Full description

Saved in:
Bibliographic Details
Main Authors ELENKO ERIC, KORTH CHRISTOPHER, PADEN HEATHER, SAHASRANAMAN SRIKUMAR, BUDHA NAGESHWAR, FILIPOVIC ALEKSANDRA
Format Patent
LanguageKorean
Published 10.06.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:티스렐리주맙과의 조합으로 항-갈렉틴-9 항체 (예를 들면, G9.2-17(IgG4))를 사용하여 고형 종양 (예를 들면, 두경부암, 요로상피 암종, 등)을 치료하는 방법. Methods for treating solid tumors (e.g., head and neck cancer, urothelial carcinoma, etc.) using an anti-Galectin-9 antibody (e.g., G9.2-17(IgG4)) in combination with tislelizumab.
Bibliography:Application Number: KR20247014491